112 related articles for article (PubMed ID: 11366134)
1. Antimicrobial agents and chemotherapy: highlights of the 38th Interscience Conference.
Prescott LM
Body Posit; 1998 Dec; 11(12):11-2. PubMed ID: 11366134
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
3. Adefovir dipivoxil (Preveon) new results with hepatitis B, HIV.
James JS
AIDS Treat News; 1998 Apr; (No 293):6-7. PubMed ID: 11365389
[TBL] [Abstract][Full Text] [Related]
4. Update from the 5th Conference on Retroviruses and Opportunistic Infections.
Vazquez E
Posit Aware; 1998; 9(3):21-3. PubMed ID: 11365483
[TBL] [Abstract][Full Text] [Related]
5. Trials for protease failure.
Posit Aware; 1998; 9(5):16-7. PubMed ID: 11365884
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral update from the Interscience Conference on Antimicrobial Agents and Chemotherapy.
Newsline People AIDS Coalit N Y; 1998 Dec; ():16-8. PubMed ID: 11367083
[TBL] [Abstract][Full Text] [Related]
7. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
Hoffmann F; Funk M; Linde R; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH; Wintergerst U
Eur J Med Res; 2002 Jul; 7(7):330-4. PubMed ID: 12176683
[TBL] [Abstract][Full Text] [Related]
8. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
9. Drugs of tomorrow.
Posit Aware; 1998; 9(3):27-31. PubMed ID: 11365484
[TBL] [Abstract][Full Text] [Related]
10. Amprenavir: new preparation. Another HIV protease inhibitor: no proven advance.
Prescrire Int; 2001 Jun; 10(53):70-2. PubMed ID: 11718166
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P
Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy: rehashes, leftovers, and a pinch of new data.
Gallant JE
Hopkins HIV Rep; 1998 Nov; 10(6):1, 4, 9-11. PubMed ID: 11366128
[TBL] [Abstract][Full Text] [Related]
13. What's new, what's next?
Fakuda D
Posit Dir News; 1998; 10(2):1, 3-7, 10. PubMed ID: 11365547
[TBL] [Abstract][Full Text] [Related]
14. What they say about: protease inhibitors.
Posit Aware; 2000; 11(1):48-54. PubMed ID: 11366351
[TBL] [Abstract][Full Text] [Related]
15. New treatment options.
Fornataro K; Jefferys R
Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013
[TBL] [Abstract][Full Text] [Related]
16. New expanded access drugs for use in combination therapy.
Newsline People AIDS Coalit N Y; 1998 Dec; ():22-3. PubMed ID: 11367085
[TBL] [Abstract][Full Text] [Related]
17. Selected highlights from the 5th Conference on Retroviruses and Opportunistic Infections.
Bartnof HS
BETA; 1998 Apr; ():49-56. PubMed ID: 11365269
[TBL] [Abstract][Full Text] [Related]
18. Lack of pharmacokinetic drug interaction between tenofovir disoproxil fumarate and nelfinavir mesylate.
Boffito M; Pozniak A; Kearney BP; Higgs C; Mathias A; Zhong L; Shah J
Antimicrob Agents Chemother; 2005 Oct; 49(10):4386-9. PubMed ID: 16189129
[TBL] [Abstract][Full Text] [Related]
19. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
[No Abstract] [Full Text] [Related]
20. Twice-daily dosing of Nelfinavir approved.
Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
